The Effect of Serum Origin on Cytokines Induced Killer Cell Expansion and Function Publisher Pubmed



Jabbarpour Z¹ ; Aghayan SS¹ ; Moradzadeh K¹ ; Ghaffari S² ; Ahmadbeigi N¹ Show Affiliations
Source: BMC Immunology Published:2023

Abstract

Background: Cytokine-induced killer (CIK) cells have shown promising results in adoptive immunotherapy. However, serum may play a determining role in the large-scale expansion of these cells for clinical applications. According to Good Manufacturing Practice (GMP) guidelines to reduce the use of animal products in cell-based therapies; therefore, this study sought to investigate the impact of serum origin and the reduced serum concentration on the pattern of cell expansion and function. Methods: Peripheral blood mononuclear cells (PBMCs) isolated from a healthy donor were expanded based on the CIK cell expansion protocol. The cell culture medium was supplemented with three types of sera comprising fetal bovine serum (FBS), human serum (HS), or human-derived platelet lysate (hPL) at different concentrations (10%, 5%, and 2.5%). The proliferation kinetics for each group were investigated for 30 days of cell culture. Results: Cell proliferation in 10% concentration of all sera (hPL, FBS, HS) was higher than their lower concentrations. Moreover, hPL was significantly associated with higher expansion rates than FBS and HS in all three concentrations. Furthermore, cells cultured in hPL showed higher viability, cytotoxicity effect, and CIK CD markers expression. Conclusion: hPL at a concentration of 10% showed the best effect on CIK cell proliferation and function. © 2023, BioMed Central Ltd., part of Springer Nature.